期刊
FREE RADICAL BIOLOGY AND MEDICINE
卷 176, 期 -, 页码 16-33出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2021.09.006
关键词
Alzheimer disease and type 2 diabetes; Oxidative and nitrosative stress; Insulin resistance; Neurodegeneration; Biliverdin reductase-A; AMP-Activated protein kinase
资金
- NIH [AG060056]
The article discusses the potential relationship between type 2 diabetes and Alzheimer's disease, highlighting the roles of oxidative stress, insulin resistance, and AMPK dysfunction in neurodegenerative disorders.
Alzheimer's disease (AD) is the most common form of dementia in the elderly followed by vascular dementia. In addition to clinically diagnosed dementia, cognitive dysfunction has been reported in diabetic patients. Recent studies are now beginning to recognize type 2 diabetes mellitus (T2DM), characterized by chronic hyperglycemia and insulin resistance, as a risk factor for AD and other cognitive disorders. While studies on insulin action have remained traditionally in the domain of peripheral tissues, the detrimental effects of insulin resistance in the central nervous system on cognitive dysfunction are increasingly being reported in recent clinical and preclinical studies. Brain functions require continuous supply of glucose and oxygen and a tight regulation of metabolic processes. Loss of this metabolic regulation has been proposed to be a contributor to memory dysfunction associated with neurodegeneration. Within the above scenario, this review will focus on the interplay among oxidative stress (OS), insulin resistance and AMPK dysfunctions in the brain by highlighting how these neurotoxic events contribute to neurodegeneration. We provide an overview on the detrimental effects of OS on proteins regulating insulin signaling and how these alterations impact cell metabolic dysfunctions through AMPK dysregulation. Such processes, we assert, are critically involved in the molecular pathways that underlie AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据